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1. INTRODUCTION 
Hepatocellular carcinoma (HCC) is the most 
common liver malignancy in the world and the 
third leading cause of cancer-related deaths. 
HCC patients for whom resection is not possible 
can be treated by transarterial therapies such as 
chemo-embolization (TACE). In TACE, particles 
are injected in the feeding arteries of the tumour 
of which the combined embolic and chemo-
therapeutic effects damage the tumour tissue. 
Since the goal of the therapy is to direct particles 
towards the tumour tissue and limit the spread to 
healthy tissue, target-specificity is a key 
parameter of TACE. In this study, computational 
fluid dynamics simulations are used to estimate 
the impact of size and location of tumor nodules 
on the particle distribution in the liver.  
 
2. MATERIALS AND METHODS 
A detailed dataset of the cirrhotic liver vasculature 
was obtained by combining vascular corrosion 
casting and micro-CT imaging. The arterial 
network of the liver was segmented using Mimics 
(Materialise, Leuven, Belgium). The resulting 
geometry was smoothed and a surface mesh was 
created in 3-matic (Materialise, Leuven, Belgium). 
A volume mesh was created in ICEM (Ansys Inc. 
Canonsburg, USA). Steady-state simulations 
were run in Ansys Fluent (Ansys. Inc, 
Canonsburg, USA). The Discrete Phase Model 
(DPM) was used to simulate particle transport. 
Regarding the boundary conditions for the 
simulations, the arterial perfusion model as 
proposed by Aramburu et al [1] was used to define 
the fractional outflow of fluid at each outlet of the 
computational domain. Particle tracks were 
processed in CFD-Post (Ansys. Inc, Canonsburg, 
USA) and MATLAB.   
 
3. RESULTS AND DISCUSSION 
Particle Release Maps (PRM; Figs. 1 and 2) are 
helpful planar visualizations of the inlet cross-
section where particles are injected. The green 
color denotes the targeting region where particles 
need to be injected in order to reach the tumor 
tissue. Injection of particles in the red region leads 
to unwanted particle deposition in the healthy 
tissue.   
In Figure 1, the PRM is given for a cancer 
scenario in which a large tumour in the left lobe 
(1130 ml) was modelled. In Figure 2, the PRM is 
given for a scenario in which a small tumour in the 
left lobe (150 ml) was modelled. It is obvious that 
the ideal targeting regions differ heavily between 
the two scenarios.  
The arterial perfusion model as proposed by 
Aramburu et al [1] shows that global and local 
cancer burden play an important role in assessing 
downstream particle distribution.  
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Figure 1: PRM – large 
tumour in left lobe 
Figure 1: PRM – small 
tumour in left lobe 
